The Indian government has taken several initiatives to develop the pharmaceutical industry and improve healthcare access in India. The Pharma Vision 2020 aims to make India a global drug discovery hub. Approval times for new facilities have been reduced and a single-window clearance system established. FDI norms have been relaxed and digital tracking of drug sales implemented. Mega bulk drug parks are being established to reduce raw material imports. The national budget increased health funding and various programs support research, women's health, and biotechnology development. The objective is for India to become self-sufficient in drug production while maintaining quality and accessibility.

1. Indian Pharma
Industry-
Government of
India’s (GOI)
initiative
PharmaCampus- All Rights reserved

2. 1. Pharma Vision
2020
PharmaCampus- All Rights reserved

3. Pharma Vision 2020
Pharma Vision 2020 by the government’s Department of
Pharmaceuticals aims to make India a major hub for end-to-
end drug discovery.
PharmaCampus- All Rights reserved

4. 2. Reduction in
approval time
for New
Facilities
PharmaCampus- All Rights reserved

5. Reduction in approval
time for New Facilities
• Steps taken to reduce approval time for
new facilities.
• NOC for export license issued in two
weeks compared to 12 weeks earlier.
PharmaCampus- All Rights reserved

6. 3. Single
Window
Clearance
PharmaCampus- All Rights reserved

7. Single Window Clearance
• As per NBDS, a proposal has
been made to set up the
National Biotechnology
Regulatory Authority
(NBRA).
• This was made to provide a
single-window clearance
mechanism for all bio-safety
products.
PharmaCampus- All Rights reserved

8. 4. Support for
Technology
Upgrades and
FDIs
PharmaCampus- All Rights reserved

9. Support for
Technology
Upgrades and FDIs
• Government is planning to relax
FDI norms in the pharmaceutical
sector
• In March 2017, the government
decided to create a digital
platform to regulate and track
the sale of quality drugs.
PharmaCampus- All Rights reserved

10. 5.
Pharmaceutical
Parks

11. Pharmaceutical Parks
• Government of India is planning to
set up mega bulk drug parks in
order to reduce industry’s
dependency on raw material
imports.
• As of October 2018, the Uttar
Pradesh Government has set up
six pharma parks in the state.
PharmaCampus- All Rights reserved

12. 6. National Commission for
Homoeopathy (NCH) Bill, 2018
PharmaCampus- All Rights reserved

13. National Commission for
Homoeopathy (NCH) Bill,
2018
• The Government of India
approved the NCH bill in December
2018 in order to have more
transparency in the sector.
PharmaCampus- All Rights reserved

14. 7. National
Biopharma
Mission

15. National Biopharma
Mission
• The Industry – Academia mission was
launched in June 2017 to boost
development of biopharmaceuticals in
India.
PharmaCampus- All Rights reserved

16. 8. Union
Budget 2019-
20
PharmaCampus- All Rights reserved

17. Union Budget 2019-20
PharmaCampus- All Rights reserved
The allocation to the Ministry of Health and Family
Welfare has increased by Rs 61,398 crore (US$
8.98 billion).
The National Health Mission Scheme is expected to
benefit 7.31 million poor families in the country by
providing a cover of up to Rs 5 lakh per family.
The government has allocated Rs 31,745 crore
(US$ 4.64 billion) towards the National Health
Mission under which rural and urban people will
get benefited.

18. 9. Biotechnology
Industry
Research
Assistance
Council
PharmaCampus- All Rights reserved

19. Biotechnology Industry
Research Assistance
Council (BIRAC)
• BIRAC has been established to promote
research & innovation capabilities in
India’s biotech industry.
• BIRAC under Small Business Innovation
Research Initiative (SBIRI) scheme
supports innovations in biotechnology.
PharmaCampus- All Rights reserved

20. 10. Biotechnology Based
Programme for Women
PharmaCampus- All Rights reserved

21. • Programme on application of
biotechnology for women was done to
provide
• Employment,
• Skill development,
• Awareness generation,
• Health improvement & socio-
economic upliftment of the women
population.
PharmaCampus- All Rights reserved

22. Objectives of National Pharmaceutical Policy
Make all essential drugs accessible to masses
through affordable prices
Provide the Indian pharmaceutical sector
with a long-term stable policy environment
Make India self sufficient in end-to-end
domestic drug manufacturing
Maintain world class quality for domestic
consumption and exports.
PharmaCampus- All Rights reserved
Create a positive environment for research and
development in the pharma sector.

23. 19.55
21.57
23.12 23.58
35.07 34.91
0
5
10
15
20
25
30
35
40
FY 13 FY 14 FY 15 FY 16 FY 17 FY 18
Government Expenditure on Health in India (US$
billion)
• Medical technology park in Vishakhapatnam, Andhra
Pradesh has already been set up with an investment of
US$ 183.31 million.
PharmaCampus- All Rights reserved
Expenditure
1.26 lakh crore in FY12
2.25 lakh crore in FY18.

24. 10% 7% 10% 7%
14%
23%
20%
21%
24% 29%
29%
15%
35% 39%
43%
50% 36% 46%
35% 32%
24%
14%
21%
16%
0%
20%
40%
60%
80%
100%
120%
2013 2014 2015 2016 2017 2018
Early Stage- Angel Early Stage- VC Growth Investments Pipe Investments
PE Investments in Indian Pharma by
Deal Type
• Received cumulative FDI worth US$ 15.93 billion between
April 2000 and December 2018.
• Witnessed 39 PE investment deals worth US$ 217 million,
between Jul-Sep 2018
• Witnessed 46 merger & acquisition (M&A) deals worth US$
1.47 billion, in 2017.
PharmaCampus- All Rights reserved
Indian Drugs & Pharmaceuticals sector

25. PharmaCampus- All Rights reserved